-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The number of mutations of the new coronavirus has increased, and the variant strains are prevalent in many countries.
While the new coronavirus vaccine has achieved effective prevention and control, where is my country's research and development of effective drugs for the new coronavirus? What are the candidate "seed medicines"? Let's take a look at the development process of China's new crown drugs
.
While the new coronavirus vaccine has achieved effective prevention and control, where is my country's research and development of effective drugs for the new coronavirus? What are the candidate "seed medicines"? Let's take a look at the development process of China's new crown drugs
.
After the outbreak of the new crown pneumonia, China immediately deployed drug research and development tasks, organized a national team of experts, and focused on clinical treatment needs to fully promote the research and development of effective drugs and treatment technologies
.
According to the relevant person in charge, 53 scientific research emergency projects in the clinical treatment and drug sector have been approved, involving about 315 million yuan of state-appropriated funds
.
.
According to the relevant person in charge, 53 scientific research emergency projects in the clinical treatment and drug sector have been approved, involving about 315 million yuan of state-appropriated funds
.
During the development of new coronavirus drugs, China has deployed three technical routes
.
At present, the research and development of effective drugs for the new coronavirus is mainly carried out around three technical routes: blocking the virus from entering cells, inhibiting virus replication, and regulating the human immune system
.
.
At present, the research and development of effective drugs for the new coronavirus is mainly carried out around three technical routes: blocking the virus from entering cells, inhibiting virus replication, and regulating the human immune system
.
Up to now, China has formed a combination therapy of BRII-196 and BRII-198 neutralizing antibodies that block virus entry into cells, procrudide, azvudine that inhibits virus replication, and a monoclonal antibody BDB-001 that modulates the human immune system.
A batch of key drugs such as injections, and a variety of effective drugs for the new coronavirus independently developed by our R&D team have been used in clinical treatment
.
A batch of key drugs such as injections, and a variety of effective drugs for the new coronavirus independently developed by our R&D team have been used in clinical treatment
.
The number of mutations of the new coronavirus has increased, and the variant strains are prevalent in many countries.
While the new coronavirus vaccine has achieved effective prevention and control, where is my country's research and development of effective drugs for the new coronavirus? What are the candidate "seed medicines"? Let's take a look at the development process of China's new crown drugs
.
While the new coronavirus vaccine has achieved effective prevention and control, where is my country's research and development of effective drugs for the new coronavirus? What are the candidate "seed medicines"? Let's take a look at the development process of China's new crown drugs
.
After the outbreak of the new crown pneumonia, China immediately deployed drug research and development tasks, organized a national team of experts, and focused on clinical treatment needs to fully promote the research and development of effective drugs and treatment technologies
.
According to the relevant person in charge, 53 scientific research emergency projects in the clinical treatment and drug sector have been approved, involving about 315 million yuan of state-appropriated funds
.
.
According to the relevant person in charge, 53 scientific research emergency projects in the clinical treatment and drug sector have been approved, involving about 315 million yuan of state-appropriated funds
.
During the development of new coronavirus drugs, China has deployed three technical routes
.
At present, the research and development of effective drugs for the new coronavirus is mainly carried out around three technical routes: blocking the virus from entering cells, inhibiting virus replication, and regulating the human immune system
.
.
At present, the research and development of effective drugs for the new coronavirus is mainly carried out around three technical routes: blocking the virus from entering cells, inhibiting virus replication, and regulating the human immune system
.
Up to now, China has formed a combination therapy of BRII-196 and BRII-198 neutralizing antibodies that block virus entry into cells, procrudide, azvudine that inhibits virus replication, and a monoclonal antibody BDB-001 that modulates the human immune system.
A batch of key drugs such as injections, and a variety of effective drugs for the new coronavirus independently developed by our R&D team have been used in clinical treatment
.
A batch of key drugs such as injections, and a variety of effective drugs for the new coronavirus independently developed by our R&D team have been used in clinical treatment
.
The number of mutations of the new coronavirus has increased, and the variant strains are prevalent in many countries.
While the new coronavirus vaccine has achieved effective prevention and control, where is my country's research and development of effective drugs for the new coronavirus? What are the candidate "seed medicines"? Let's take a look at the development process of China's new crown drugs
.
While the new coronavirus vaccine has achieved effective prevention and control, where is my country's research and development of effective drugs for the new coronavirus? What are the candidate "seed medicines"? Let's take a look at the development process of China's new crown drugs
.
After the outbreak of the new crown pneumonia, China immediately deployed drug research and development tasks, organized a national team of experts, and focused on clinical treatment needs to fully promote the research and development of effective drugs and treatment technologies
.
According to the relevant person in charge, 53 scientific research emergency projects in the clinical treatment and drug sector have been approved, involving about 315 million yuan of state-appropriated funds
.
.
According to the relevant person in charge, 53 scientific research emergency projects in the clinical treatment and drug sector have been approved, involving about 315 million yuan of state-appropriated funds
.
During the development of new coronavirus drugs, China has deployed three technical routes
.
At present, the research and development of effective drugs for the new coronavirus is mainly carried out around three technical routes: blocking the virus from entering cells, inhibiting virus replication, and regulating the human immune system
.
.
At present, the research and development of effective drugs for the new coronavirus is mainly carried out around three technical routes: blocking the virus from entering cells, inhibiting virus replication, and regulating the human immune system
.
Up to now, China has formed a combination therapy of BRII-196 and BRII-198 neutralizing antibodies that block virus entry into cells, procrudide, azvudine that inhibits virus replication, and a monoclonal antibody BDB-001 that modulates the human immune system.
A batch of key drugs such as injections, and a variety of effective drugs for the new coronavirus independently developed by our R&D team have been used in clinical treatment
.
A batch of key drugs such as injections, and a variety of effective drugs for the new coronavirus independently developed by our R&D team have been used in clinical treatment
.
